119 related articles for article (PubMed ID: 36843509)
1. Early Initiation of HPV Vaccination and Series Completion in Early and Mid-Adolescence.
Goodman E; Felsher M; Wang D; Yao L; Chen YT
Pediatrics; 2023 Mar; 151(3):. PubMed ID: 36843509
[TBL] [Abstract][Full Text] [Related]
2. Area-based socioeconomic factors and Human Papillomavirus (HPV) vaccination among teen boys in the United States.
Henry KA; Swiecki-Sikora AL; Stroup AM; Warner EL; Kepka D
BMC Public Health; 2017 Jul; 18(1):19. PubMed ID: 28709420
[TBL] [Abstract][Full Text] [Related]
3. Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen.
Bednarczyk RA; Brandt HM
Hum Vaccin Immunother; 2023 Dec; 19(1):2204784. PubMed ID: 37138466
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid.
Inguva S; Barnard M; Ward LM; Yang Y; Pittman E; Banahan BF; Kirby TR; Noble SL
Vaccine; 2020 Feb; 38(8):2051-2057. PubMed ID: 31980196
[TBL] [Abstract][Full Text] [Related]
5. Effect of age at initiation of the human papillomavirus vaccine on the association between race/ethnicity and completion of the vaccine series.
Hirth J; Ostovar-Kermani T; Gutierrez JA; Thompson EL; Barnett TE; Zoorob R
Vaccine; 2024 Apr; 42(11):2827-2836. PubMed ID: 38519345
[TBL] [Abstract][Full Text] [Related]
6. Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.
Adjei Boakye E; Lew D; Muthukrishnan M; Tobo BB; Rohde RL; Varvares MA; Osazuwa-Peters N
Hum Vaccin Immunother; 2018; 14(8):2016-2024. PubMed ID: 29708826
[TBL] [Abstract][Full Text] [Related]
7. Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018.
Chido-Amajuoyi OG; Talluri R; Wonodi C; Shete S
Pediatrics; 2021 Jun; 147(6):. PubMed ID: 33941585
[TBL] [Abstract][Full Text] [Related]
8. Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination: A Cluster Randomized Clinical Trial.
Dempsey AF; Pyrznawoski J; Lockhart S; Barnard J; Campagna EJ; Garrett K; Fisher A; Dickinson LM; O'Leary ST
JAMA Pediatr; 2018 May; 172(5):e180016. PubMed ID: 29507952
[TBL] [Abstract][Full Text] [Related]
9. Association Between Human Papillomavirus Vaccination School-Entry Requirements and Vaccination Initiation.
Ko JS; Goldbeck CS; Baughan EB; Klausner JD
JAMA Pediatr; 2020 Sep; 174(9):861-867. PubMed ID: 32597928
[TBL] [Abstract][Full Text] [Related]
10. The association of initiating HPV vaccination at ages 9-10 years and up-to-date status among adolescents ages 13-17 years, 2016-2020.
Minihan AK; Bandi P; Star J; Fisher-Borne M; Saslow D; Jemal A
Hum Vaccin Immunother; 2023 Dec; 19(1):2175555. PubMed ID: 36748322
[TBL] [Abstract][Full Text] [Related]
11. Regional variation in human papillomavirus vaccination uptake and completion among adolescents 13-17 in the state of Texas.
Conrey R; Valencia V; Cioletti A; Williams-Brown MY
Vaccine; 2020 May; 38(25):4119-4124. PubMed ID: 32349907
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus vaccination series initiation and completion, 2008-2009.
Dorell CG; Yankey D; Santibanez TA; Markowitz LE
Pediatrics; 2011 Nov; 128(5):830-9. PubMed ID: 22007006
[TBL] [Abstract][Full Text] [Related]
13. From non school-based, co-payment to school-based, free Human Papillomavirus vaccination in Flanders (Belgium): a retrospective cohort study describing vaccination coverage, age-specific coverage and socio-economic inequalities.
Lefevere E; Theeten H; Hens N; De Smet F; Top G; Van Damme P
Vaccine; 2015 Sep; 33(39):5188-95. PubMed ID: 26254978
[TBL] [Abstract][Full Text] [Related]
14. Racial/ethnic disparities in human papillomavirus vaccination initiation and completion among U.S. women in the post-Affordable Care Act era.
Agénor M; Pérez AE; Peitzmeier SM; Borrero S
Ethn Health; 2020 Apr; 25(3):393-407. PubMed ID: 29347831
[No Abstract] [Full Text] [Related]
15. Quality Improvement Project to Increase Human Papillomavirus Two-Dose Vaccine Series Completion by 13 Years in Pediatric Primary Care Clinics.
Smajlovic A; Toth CD
J Adolesc Health; 2023 Jun; 72(6):958-963. PubMed ID: 36925411
[TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus Vaccination Among Adults and Children in 5 US States.
Du P; Camacho F; McCall-Hosenfeld J; Lengerich E; Meyers CM; Christensen ND
J Public Health Manag Pract; 2015; 21(6):573-83. PubMed ID: 26035648
[TBL] [Abstract][Full Text] [Related]
17. Rural-Urban Disparities in HPV Vaccination Coverage Among Adolescents in the Central Part of the State of Illinois, USA.
Adjei Boakye E; Fedorovich Y; White M; Vohra S; Volle M; Osazuwa-Peters N; Gerend MA
J Community Health; 2023 Feb; 48(1):24-29. PubMed ID: 36066667
[TBL] [Abstract][Full Text] [Related]
18. HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US.
Saxena K; Kathe N; Sardana P; Yao L; Chen YT; Brewer NT
Hum Vaccin Immunother; 2023 Dec; 19(1):2161253. PubMed ID: 36631995
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With HPV Vaccine Initiation, Vaccine Completion, and Accuracy of Self-Reported Vaccination Status Among 13- to 26-Year-Old Men.
Thomas R; Higgins L; Ding L; Widdice LE; Chandler E; Kahn JA
Am J Mens Health; 2018 Jul; 12(4):819-827. PubMed ID: 27106515
[TBL] [Abstract][Full Text] [Related]
20. Clinician knowledge, clinician barriers, and perceived parental barriers regarding human papillomavirus vaccination: Association with initiation and completion rates.
Rutten LJ; St Sauver JL; Beebe TJ; Wilson PM; Jacobson DJ; Fan C; Breitkopf CR; Vadaparampil ST; Jacobson RM
Vaccine; 2017 Jan; 35(1):164-169. PubMed ID: 27887795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
